regulus therapeutics inc
Kleanthis G. Xanthopoulos Ph.D.
|Age||Total Calculated Compensation||This person is connected to 128 board members in 5 different organizations across 11 different industries.|
See Board Relationships
As of Fiscal Year 2014
Dr. Kleanthis G. Xanthopoulos, Ph.D. served as the Chief Executive Officer and President of Regulus Therapeutics Inc., from January 2009 to June 2015 and also served as its Principal Financial & Accounting Officer since June 21, 2013. Dr. Xanthopoulos serves as the Managing Director of Life Science Investments at Novera Optics, Inc. He serves as Senior Vice President at Isis Pharmaceuticals, Inc. He serves as a Member of the Executive Board at BIOCOM, Inc. He founded ...
3545 John Hopkins CourtPhone: 858-202-6300
San Diego, California 92121
Board Members Memberships*
Founder and Director
Chairman of the Board
Director, Chairman of Nominating & Corporate Governance Committee, Chairman of Compensation Committee and Member of Audit Committee
University of Thessaloniki
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Ron Cohen M.D.||Founder, Chief Executive Officer, President and Director|
Acorda Therapeutics, Inc.
|Edward M. Kaye M.D., Ph.D.||Interim Chief Executive Officer, Chief Medical Officer and Senior Vice President|
Sarepta Therapeutics, Inc.
|James A. Schoeneck||Chief Executive Officer, President and Director|
|Stephen R. Davis J.D.||Interim Chief Executive Officer, Chief Financial Officer, Chief Business Officer and Executive Vice President|
ACADIA Pharmaceuticals Inc.
|John M. Maraganore M.D., Ph.D.||Chief Executive Officer and Executive Director|
Alnylam Pharmaceuticals, Inc.
|$689.6K||Compensation as of Fiscal Year 2014.|